Pfizer, Inc. v. Genentech, Inc. > Summary
Court Case Number IPR2017-02063
Filing Date Sep 6, 2017
Institution Decision Date Feb 21, 2018
Decision Date Oct 3, 2018
Court Patent Trial and Appeal Board
Status Final Written Decision
Appeal2019-1263
Administrative JudgesZhenyu Yang, Christopher G. Paulraj, Robert A. Pollock
Judge Writing the Final DecisionZhenyu Yang
Claims Challenged in the Petition: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
Claims Instituted: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
Claims Invalidated: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
Petitioner
Patent Owner
Petitioner Attorneys
10Pfizer Legal Division 2
Attorney Name: Christopher J. Citro
Kirkland & Ellis
Pfizer Legal Division 2
Attorney Name: Mark C. McLennan
Kirkland & Ellis
Pfizer Legal Division 2
Attorney Name: Sarah K. Tsou
Kirkland & Ellis
Pfizer Legal Division 2
Attorney Name: Benjamin A. Lasky
Kirkland & Ellis
Pfizer Legal Division 2
Attorney Name: Karen Lynn Younkins
Kirkland & Ellis
Pfizer Legal Division 2
Attorney Name: Stefan M. Miller
Kirkland & Ellis
Pfizer Legal Division 2
Attorney Name: Amanda Hollis
Kirkland & Ellis
Pfizer Legal Division 2
Attorney Name: Cynthia Lambert Hardman
Goodwin Procter LLP
Pfizer Legal Division 2
Attorney Name: Alan R. Lipton
Pfizer
Pfizer Legal Division 2
Attorney Name: Mark X. Sliwkowski
Pfizer
Patent Owner Attorneys
8Genentech, Inc
Attorney Name: Daralyn J. Durie
Morrison & Foerster
Genentech, Inc
Attorney Name: Adam R. Brausa
Morrison & Foerster
Genentech, Inc
Attorney Name: Rebecca A. Whitfield
Wilmer Cutler Pickering Hale and Dorr
Genentech, Inc
Attorney Name: David L. Cavanaugh
Wilmer Cutler Pickering Hale and Dorr
Genentech, Inc
Attorney Name: Owen K. Allen
Wilmer Cutler Pickering Hale and Dorr
Genentech, Inc
Attorney Name: Kevin S. Prussia
Wilmer Cutler Pickering Hale and Dorr
Genentech, Inc
Attorney Name: Robert J. Gunther Jr.
Wilmer Cutler Pickering Hale and Dorr
Genentech, Inc
Attorney Name: Andrew J. Danford
Wilmer Cutler Pickering Hale and Dorr
Related Patents
Doc No | Title | Issue date |
---|---|---|
07846441 | Treatment with anti-ErbB2 antibodies | Dec 7, 2010 |